Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MRG-004A by Shanghai Miracogen for Cervical Cancer: Likelihood of Approval
MRG-004A is under clinical development by Shanghai Miracogen and currently in Phase II for Cervical Cancer. According to GlobalData, Phase...
MRG-004A by Shanghai Miracogen for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
MRG-004A is under clinical development by Shanghai Miracogen and currently in Phase II for Triple-Negative Breast Cancer (TNBC). According to...
MRG-004A by Shanghai Miracogen for Pancreatic Cancer: Likelihood of Approval
MRG-004A is under clinical development by Shanghai Miracogen and currently in Phase II for Pancreatic Cancer. According to GlobalData, Phase...